Anti‑demodectic effects of okra eyelid patch in <em>Demodex</em> blepharitis compared with tea tree oil

Liu,Wenting; Gong,Lan

doi:10.3892/etm.2021.9769

Anti‑demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil

Authors:
- Wenting Liu
- Lan Gong
View Affiliations

Affiliations: Department of Ophthalmology and Vision Science, The Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai 200031, P.R. China
Published online on: February 10, 2021 https://doi.org/10.3892/etm.2021.9769
Article Number: 338
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Demodex infection gradually develops to Demodex blepharitis, which is characterized as chronic inflammation of the eyelid and meibomian gland (MG) and ultimately leads to MG dysfunction. In the present prospective study, the anti‑demodectic effects of an okra eyelid patch in patients Demodex blepharitis were investigated. A total of 52 patients with Demodex blepharitis with ocular discomfort were recruited. Patients were randomized to receive either an okra eyelid patch treatment (treatment group, n=27) or tea tree oil (TTO) eye care patch treatment (control group, n=25) for three months. The Demodex count, the ocular surface disease index (OSDI) score, MG expressibility (MGE) and meibum quality, Schirmer I test (SIT), tear break‑up time (TBUT) and corneal fluorescein staining (CFS) were determined prior to treatment and after 1 and 3 months of treatment. Changes in the parameters were compared between the treatment group and control group after 1 and 3 months of treatment. The average survival time in the okra group was 115.25±11.87 min, which was significantly lower compared with the average ST of 378.75±37.94 min in the blank group (P<0.01). After 3 months of okra eyelid patch treatment, the Demodex count was significantly reduced from 10.15±4.53 to 1.30±1.41 (P<0.01) and the OSDI score of the patients was reduced by 16.84±10.17 (P<0.01). There was no significant difference in the Demodex count (P=0.716) and OSDI (P=0.873) between the treatment and control groups. The rate of complete Demodex eradication in the treatment group (11/27, 40.74%) was slightly lower than that in the control group (12/25, 48%), but there was no significant difference between the two groups (χ²=0.277, P=0.598). Regarding the other ocular parameters, no significant difference was observed in the TBUT, meibum quality and MGE between the two groups (P<0.05). TTO group has a significantly improvement compared with Okra group in terms of SIT (P=0.035) and CFS (P=0.023). In conclusion, okra eyelid patch treatment is able to significantly eradicate ocular Demodex as well as markedly alleviate ocular symptoms. Due to causing less irritation than TTO, the okra eyelid patch may be more suitable for sensitive patients with Demodex blepharitis, such as the elderly and children. The study was registered as a clinical trial in the Chinese Clinical Trial Registry (ChiCTR) in November 2018 (registration no. ChiCTR‑1,800,019,466).

View Figures

View References

1	Basta-Juzbasić A, Subić JS and Ljubojević S: Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases. Clin Dermatol. 20:135–140. 2002.PubMed/NCBI View Article : Google Scholar
2	Wesolowska M, Knysz B, Reich A, Blazejewska D, Czarnecki M, Gladysz A, Pozowski A and Misiuk-Hojlo M: Prevalence of Demodex spp. in eyelash follicles in different populations. Arch Med Sci. 10:319–324. 2014.PubMed/NCBI View Article : Google Scholar
3	Zhang XB, Ding YH and He W: The association between Demodex infestation and ocular surface manifestations in meibomian gland dysfunction. Int J Ophthalmol. 11:589–592. 2018.PubMed/NCBI View Article : Google Scholar
4	Fromstein SR, Harthan JS, Patel J and Opitz DL: Demodex blepharitis: Clinical perspectives. Clin Optom (Auckl). 10:57–63. 2018.PubMed/NCBI View Article : Google Scholar
5	Luo X, Li J, Chen C, Tseng S and Liang L: Ocular demodicosis as a potential cause of ocular surface inflammation. Cornea. 36 (Suppl 1):S9–S14. 2017.PubMed/NCBI View Article : Google Scholar
6	Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, et al: TFOS DEWS II pathophysiology report. Ocul Surf. 15:438–510. 2017.PubMed/NCBI View Article : Google Scholar
7	Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R and Dogru M: The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 52:2006–2049. 2011.PubMed/NCBI View Article : Google Scholar
8	Gao YY, Di Pascuale MA, Li W, Baradaran-Rafii A, Elizondo A, Kuo CL, Raju VK and Tseng SC: In vitro and in vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol. 89:1468–1473. 2005.PubMed/NCBI View Article : Google Scholar
9	Doreddula SK, Bonam SR, Gaddam DP, Desu BS, Ramarao N and Pandy V: Phytochemical analysis, antioxidant, antistress, and nootropic activities of aqueous and methanolic seed extracts of ladies finger (Abelmoschus esculentus L.) in mice. ScientificWorldJournal. 2014(519848)2014.PubMed/NCBI View Article : Google Scholar
10	Adelakun OE, Oyelade OJ, Ade-Omowaye BI, Adeyemi IA and Van de Venter M: Chemical composition and the antioxidative properties of nigerian okra seed (Abelmoschus esculentus Moench) flour. Food Chem Toxicol. 47:1123–1126. 2009.PubMed/NCBI View Article : Google Scholar
11	Liao H, Dong W, Shi X, Liu H and Yuan K: Analysis and comparison of the active components and antioxidant activities of extracts from Abelmoschus esculentus L. Pharmacogn Mag. 8:156–161. 2012.PubMed/NCBI View Article : Google Scholar
12	Cho CW, Han CJ, Rhee YK, Lee YC, Shin KS, Shin JS, Lee KT and Hong HD: Cheonggukjang polysaccharides enhance immune activities and prevent cyclophosphamide-induced immunosuppression. Int J Biol Macromol. 72:519–525. 2015.PubMed/NCBI View Article : Google Scholar
13	Durazzo A, Lucarini M, Novellino E, Souto EB, Daliu P and Santini A: Abelmoschus esculentus (L.): Bioactive components' beneficial properties-focused on antidiabetic role-for sustainable health applications. Molecules. 24(38)2018.PubMed/NCBI View Article : Google Scholar
14	Mairuae N, Cheepsunthorn P, Cheepsunthorn CL and Tongjaroenbuangam W: Okra (Abelmoschus esculentus Linn) inhibits lipopolysaccharide-induced inflammatory mediators in BV2 microglial cells. Trop J Pharm Res. 16(1285)2017.PubMed/NCBI View Article : Google Scholar
15	Zhang X, Yin Y, Yue L and Gong L: Selective serotonin reuptake inhibitors aggravate depression-associated dry eye via activating the NF-κB pathway. Invest Ophthalmol Vis Sci. 60:407–419. 2019.PubMed/NCBI View Article : Google Scholar
16	Yang FM, Fan D, Yang XQ, Zhu FH, Shao MJ, Li Q, Liu YT, Lin ZM, Cao SQ, Tang W, et al: The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling. Acta Pharmacol Sin: Aug 3, 2020 (Epub ahead of print).
17	Gao YY, Di Pascuale MA, Li W, Liu DT, Baradaran-Rafii A, Elizondo A, Kawakita T, Raju VK and Tseng SC: High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 46:3089–3094. 2005.PubMed/NCBI View Article : Google Scholar
18	Kheirkhah A, Blanco G, Casas V and Tseng SC: Fluorescein dye improves microscopic evaluation and counting of demodex in blepharitis with cylindrical dandruff. Cornea. 26:697–700. 2007.PubMed/NCBI View Article : Google Scholar
19	Salem DA, El-Shazly A, Nabih N, El-Bayoumy Y and Saleh S: Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis. 17:e343–e347. 2013.PubMed/NCBI View Article : Google Scholar
20	Zhang X, Song N and Gong L: Therapeutic effect of intense pulsed light on ocular demodicosis. Curr Eye Res. 44:250–256. 2019.PubMed/NCBI View Article : Google Scholar
21	Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD and Reis BL: Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 118:615–621. 2000.PubMed/NCBI View Article : Google Scholar
22	Yokoi N, Georgiev GA, Kato H, Komuro A, Sonomura Y, Sotozono C, Tsubota K and Kinoshita S: Classification of fluorescein breakup patterns: A novel method of differential diagnosis for dry eye. Am J Ophthalmol. 180:72–85. 2017.PubMed/NCBI View Article : Google Scholar
23	Lemp MA: Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J. 21:221–232. 1995.PubMed/NCBI
24	Bevins CL and Liu FT: Rosacea: Skin innate immunity gone awry? Nat Med. 13:904–906. 2007.PubMed/NCBI View Article : Google Scholar
25	Gao YY, Di Pascuale MA, Elizondo A and Tseng SC: Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea. 26:136–143. 2007.PubMed/NCBI View Article : Google Scholar
26	Tighe S, Gao YY and Tseng SC: Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites. Transl Vis Sci Technol. 2(2)2013.PubMed/NCBI View Article : Google Scholar
27	Koo H, Kim TH, Kim KW, Wee SW, Chun YS and Kim JC: Ocular surface discomfort and Demodex: Effect of tea tree oil eyelid scrub in Demodex blepharitis. J Korean Med Sci. 27:1574–1579. 2012.PubMed/NCBI View Article : Google Scholar
28	Messing J, Thöle C, Niehues M, Shevtsova A, Glocker E, Borén T and Hensel A: Antiadhesive properties of Abelmoschus esculentus (Okra) immature fruit extract against Helicobacter pylori adhesion. PLoS One. 9(e84836)2014.
29	Lengsfeld C, Titgemeyer F, Faller G and Hensel A: Glycosylated compounds from okra inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Agric Food Chem. 52:1495–1503. 2004.PubMed/NCBI View Article : Google Scholar
30	Wahyuningsih SPA, Pramudya M, Putri IP, Winarni D, Savira NII and Darmanto W: Crude polysaccharides from okra pods (Abelmoschus esculentus) grown in indonesia enhance the immune response due to bacterial infection. Adv Pharmacol Sci. 2018(8505383)2018.PubMed/NCBI View Article : Google Scholar
31	Polito L, Bortolotti M, Maiello S, Battelli MG and Bolognesi A: Plants producing ribosome-inactivating proteins in traditional medicine. Molecules. 21(1560)2016.PubMed/NCBI View Article : Google Scholar
32	Liu JX, Sun YH and Li CP: Volatile oils of Chinese crude medicines exhibit antiparasitic activity against human Demodex with no adverse effects in vivo. Exp Ther Med. 9:1304–1308. 2015.PubMed/NCBI View Article : Google Scholar
33	Lehnhardt Pires C, Rodrigues SD, Bristot D, Gaeta HH, de Oliveira Toyama D, Lobo Farias WR and Toyama MH: Evaluation of macroalgae sulfated polysaccharides on the leishmania (L.) amazonensis promastigote. Mar Drugs. 11:934–943. 2013.PubMed/NCBI View Article : Google Scholar
34	Jiang MH, Zhu L and Jiang JG: Immunoregulatory actions of polysaccharides from Chinese herbal medicine. Expert Opin Ther Targets. 14:1367–1402. 2010.PubMed/NCBI View Article : Google Scholar
35	Shui G and Peng LL: An improved method for the analysis of major antioxidants of hibiscus esculentus Linn. J Chromatogr A. 1048:17–24. 2004.PubMed/NCBI View Article : Google Scholar
36	Chen H, Jiao H, Cheng Y, Xu K, Jia X, Shi Q, Guo S, Wang M, Du L and Wang F: In vitro and in vivo immunomodulatory activity of okra (Abelmoschus esculentus L.) polysaccharides. J Med Food. 19:253–265. 2016.PubMed/NCBI View Article : Google Scholar
37	Hu L, Yu W, Li Y, Prasad N and Tang Z: Antioxidant activity of extract and its major constituents from okra seed on rat hepatocytes injured by carbon tetrachloride. Biomed Res Int. 2014(341291)2014.PubMed/NCBI View Article : Google Scholar
38	Khomsug P, Thongjaroe W, Pakdeenaro N, Suttajit M and Chantirati P: Antioxidative activities and phenolic content of extracts from okra (Abelmoschus esculentus L.). Res J Biol Sci. 5:310–313. 2010.
39	Chi W, Hua X, Chen X, Bian F, Yuan X, Zhang L, Wang X, Chen D, Deng R, Li Z, et al: Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. J Autoimmun. 80:65–76. 2017.PubMed/NCBI View Article : Google Scholar
40	Saravanan S, Pandikumar P, Pazhanivel N, Paulraj MG and Ignacimuthu S: Hepatoprotective role of Abelmoschus esculentus (Linn.) moench., on carbon tetrachloride-induced liver injury. Toxicol Mech Methods. 23:528–536. 2013.PubMed/NCBI View Article : Google Scholar
41	Powell FC: Clinical practice. Rosacea. N Engl J Med. 352:793–803. 2005.PubMed/NCBI View Article : Google Scholar
42	Li J, O'Reilly N, Sheha H, Katz R, Raju VK, Kavanagh K and Tseng SC: Correlation between ocular Demodex infestation and serum immunoreactivity to bacillus proteins in patients with facial rosacea. Ophthalmology. 117:870–877.e1. 2010.PubMed/NCBI View Article : Google Scholar
43	Baldwin HE: Diagnosis and treatment of rosacea: State of the art. J Drugs Dermatol. 11:725–730. 2012.PubMed/NCBI
44	Huang CN, Wang CJ, Lee YJ and Peng CH: Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced β cell apoptosis via inhibiting dipeptidyl peptidase-4. PLoS One. 12(e0180285)2017.PubMed/NCBI View Article : Google Scholar
45	Mollick MMR, Bhowmick B, Mondal D, Maity D, Rana D, Dash SK, Chattopadhyay S, Roy S, Sarkar J, Acharya K, et al: Anticancer (in vitro) and antimicrobial effect of gold nanoparticles synthesized using Abelmoschus esculentus (L.) pulp extract via a green route. RSC Adv. 4:37838–37848. 2014.